EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetics of Ceftazidime After a Single Intramuscular Dose in Whitespotted Bamboo Sharks ( Chiloscyllium plagiosum )

Miceala Shocklee iD, Jennifer Russell, Kelsey Herrick, Todd L Schmitt iD, Todd R Robeck, Mark G Papich iD

Journal of Veterinary Pharmacology and Therapeutics · 2025

DOI: 10.1111/jvp.70031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2025. Verfasst von Miceala Shocklee und 5 weiteren Autor:innen. Beteiligte Einrichtung: SeaWorld Yas Island, Abu Dhabi, UAE. Hauptthemen laut MEDLINE: Sharks, Anti-Bacterial Agents, Ceftazidime. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Whitespotted bamboo sharks ( Chiloscyllium plagiosum ) are a common species of elasmobranchs housed in zoos and aquaria. Medical concerns like conspecific trauma and bacterial infections commonly lead to the empirical use of antibiotic medications like ceftazidime, despite limited pharmacokinetic studies in elasmobranchs. In this study, 36 whitespotted bamboo sharks were divided into six groups using a population pharmacokinetic design. They were administered a single intramuscular injection of ceftazidime at 20 mg/kg. Blood samples were collected for plasma drug concentration at time points T = 0 and 30 min, and 1, 2, 4, 6, 12, 24, 48, 72, and 96 h post‐injection. Samples were analyzed by the Clinical Pharmacology Laboratory in the College of Veterinary Medicine of North Carolina State University using high‐pressure liquid chromatography (HPLC) analysis. For at least 96 h, all sharks in the study maintained plasma concentrations of ceftazidime above the MIC of 4 μg/mL, which is considered susceptible when testing isolates from other animals. The long elimination half‐time of 84.15 h suggests that recommended dosing intervals may be extended beyond the commonly used 3 days to at least every 96 h.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SharksAnti-Bacterial AgentsCeftazidimeAnimalsInjections, IntramuscularHalf-LifeFemaleMaleArea Under Curve

Stichwörter der Autor:innen

Chiloscylliumceftazidimecephalosporinelasmobranchpharmacokinetics

Substanzen

Anti-Bacterial AgentsCeftazidime

Autor:innen und Institutionen

  • SeaWorld Yas Island, Abu Dhabi, UAE.
  • SeaWorld San Diego, San Diego, California, USA.
  • SeaWorld Parks and Entertainment, Orlando, Florida, USA.
  • College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.

ORCID-Profile: Miceala Shocklee, Todd L Schmitt, Mark G Papich

Zitieren

APA

Shocklee, M., Russell, J., Herrick, K., Schmitt, T. L., Robeck, T. R., & Papich, M. G. (2025). Pharmacokinetics of Ceftazidime After a Single Intramuscular Dose in Whitespotted Bamboo Sharks ( Chiloscyllium plagiosum ). Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.70031

Vancouver

Shocklee M, Russell J, Herrick K, Schmitt TL, Robeck TR, Papich MG. Pharmacokinetics of Ceftazidime After a Single Intramuscular Dose in Whitespotted Bamboo Sharks ( Chiloscyllium plagiosum ). Journal of Veterinary Pharmacology and Therapeutics. 2025. doi:10.1111/jvp.70031

BibTeX
@article{Shocklee2025,
  author = {Shocklee, Miceala and Russell, Jennifer and Herrick, Kelsey and Schmitt, Todd L and Robeck, Todd R and Papich, Mark G},
  title = {Pharmacokinetics of Ceftazidime After a Single Intramuscular Dose in Whitespotted Bamboo Sharks ( Chiloscyllium plagiosum )},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2025},
  doi = {10.1111/jvp.70031}
}
Kostenlos starten →